You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study

Article metrics

Article menu
Download PDFPDF
Poster Presentations
SLE, Sjögren's and APS - treatment
THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20151100
Jul 2015800
Aug 2015500
Sep 20151201
Oct 2015201
Nov 2015802
Dec 2015502
Jan 2016500
Feb 2016200
Mar 2016301
Apr 2016200
May 2016302
Jun 2016700
Jul 2016300
Aug 2016400
Sep 2016601
Oct 2016200
Nov 2016200
Dec 2016200
Jan 2017300
Feb 2017300
Mar 2017400
Apr 2017200
May 2017100
Jun 2017501
Jul 2017403
Aug 2017600
Sep 2017200
Oct 2017800
Nov 2017600
Dec 2017401
Jan 2018400
Feb 2018800
Mar 20181200
Apr 2018401
May 2018400
Jun 2018600
Jul 2018600
Aug 2018200
Sep 20181000
Nov 2018200
Dec 2018200
Jan 2019600
Feb 2019801
Mar 2019201
Apr 2019400
Jul 2019200
Aug 2019601
Oct 2019200
Nov 2019600
Dec 2019400
Mar 2020200
Apr 2020200
May 2020800
Jun 2020800
Jul 2020600
Aug 2020400
Sep 20203400
Oct 20201000
Nov 2020800
Dec 2020600
Jan 2021200
Feb 2021200
May 2021300
Oct 2021500
Nov 2021901
Dec 2021400
Jan 2022500
Feb 2022500
Mar 2022802
May 2022800
Jun 2022600
Jul 20223600
Aug 20221100
Sep 2022800
Oct 2022200
Nov 2022800
Dec 2022900
Jan 2023700
Feb 2023700
Mar 2023300
May 2023700
Jun 20232201
Jul 2023200
Aug 2023201
Sep 2023500
Oct 2023100
Nov 2023300
Dec 20231100
Jan 2024400
Feb 2024700
Mar 2024400
Total544024